Print

Intercell AG And Statens Serum Institut (SSI) Sign Cooperation And License 
10/19/2005 5:10:29 PM

Intercell AG and Statens Serum Institut (SSI) today announced the signature of a commercial license agreement for the development of a new prophylactic tuberculosis vaccine.
//-->